IL208723A0 - Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications - Google Patents

Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications

Info

Publication number
IL208723A0
IL208723A0 IL208723A IL20872310A IL208723A0 IL 208723 A0 IL208723 A0 IL 208723A0 IL 208723 A IL208723 A IL 208723A IL 20872310 A IL20872310 A IL 20872310A IL 208723 A0 IL208723 A0 IL 208723A0
Authority
IL
Israel
Prior art keywords
plasmatic
obtaining
pharmaceutical composition
different therapeutic
levels required
Prior art date
Application number
IL208723A
Other languages
English (en)
Original Assignee
Posi Visionary Solutions Llp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Posi Visionary Solutions Llp filed Critical Posi Visionary Solutions Llp
Publication of IL208723A0 publication Critical patent/IL208723A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL208723A 2008-04-14 2010-10-14 Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications IL208723A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2008/000051 WO2009128692A1 (es) 2008-04-14 2008-04-14 Método y composición farmacéutica para lograr niveles plasmáticos de progesterona requeridos para diferentes indicaciones terapéuticas

Publications (1)

Publication Number Publication Date
IL208723A0 true IL208723A0 (en) 2010-12-30

Family

ID=41199287

Family Applications (1)

Application Number Title Priority Date Filing Date
IL208723A IL208723A0 (en) 2008-04-14 2010-10-14 Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications

Country Status (8)

Country Link
US (1) US20110104289A1 (enExample)
EP (1) EP2272519A4 (enExample)
JP (1) JP2011516606A (enExample)
CN (1) CN102056611A (enExample)
BR (1) BRPI0822165A2 (enExample)
CA (1) CA2721509A1 (enExample)
IL (1) IL208723A0 (enExample)
WO (1) WO2009128692A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
KR20170040209A (ko) 2014-07-29 2017-04-12 쎄러퓨틱스엠디, 인코퍼레이티드 경피 크림
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3080456A1 (en) * 2017-10-30 2019-05-09 Carmentix Pte. Ltd. Biomarkers of preterm birth

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663223B1 (fr) * 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.
FR2663224B1 (fr) 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
JPH0474117A (ja) * 1990-07-16 1992-03-09 Kokuritsu Eisei Shikenjo 新規なマイクロスフェア
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
US7589082B2 (en) * 2003-06-13 2009-09-15 Skendi Finance Ltd Pharmaceutical formulation for contraception and hormone-replacement therapy

Also Published As

Publication number Publication date
EP2272519A4 (en) 2011-04-27
CA2721509A1 (en) 2009-10-22
WO2009128692A1 (es) 2009-10-22
BRPI0822165A2 (pt) 2015-06-16
US20110104289A1 (en) 2011-05-05
JP2011516606A (ja) 2011-05-26
CN102056611A (zh) 2011-05-11
EP2272519A1 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
EP2272519A4 (en) METHOD AND PHARMACEUTICAL COMPOSITION FOR ACHIEVING THE PLASMA PROGESTERONE MIRRORS NECESSARY FOR VARIOUS THERAPEUTIC INDICATIONS
IL216668A0 (en) Pharmaceutical composition and treatment method for emergrncy contraception
EP2021084A4 (en) METHOD AND APPARATUS FOR AUTOMATIC DELIVERY OF THERAPEUTIC EXERCISES OF UPPER MEMBERS
EP2265731A4 (en) METHODS AND COMPOSITION FOR EVALUATING MEDICATION RESPONSE
EP2207519A4 (en) MIXING SYSTEM AND MIXING METHOD FOR MEDICAL PURPOSES
IL201046A0 (en) Method and device for drug delivery
IL219910A0 (en) Device and method for delivery of two or more drug agents
EP2265314A4 (en) METHOD AND DEVICES FOR DELIVERING INJECTIONS
IL212767A0 (en) Device and method for drug delivery
EP2180873A4 (en) THERAPEUTIC DENTAL COMPOSITION AND RELATED METHODS
IL205147A0 (en) Lumen probe apparatuses and methods for using the same
IL207569A0 (en) Compositions and methods for drug delivery
GB0802402D0 (en) Medical device and method
IL210755A0 (en) Devices and methods for forming tracts in tissue
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
EP2216639A4 (en) APPARATUS AND METHOD FOR MEASURING BLOOD FLUIDITY
GB0716464D0 (en) Medical device and method
ZA200902084B (en) Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
PL1870641T3 (pl) Urządzenie odparowujące i sposób eksploatacji urządzenia odparowującego
EP2219020A4 (en) SYSTEM AND METHOD FOR MEASURING THE BLOOD-FLOWING CAPACITY
IL195764A0 (en) Compositions and methods for drug delivery
TWI368990B (en) Display apparatus and method for making the same
IL198723A0 (en) Methods and compositions for therapeutic treatment
HUP0700369D0 (en) Pharmaceutical compositions and method for treating schizofrenia